Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Nihon Chouzai Co ( (JP:3341) ) has shared an announcement.
Nihon Chouzai Co., Ltd. has announced an impairment loss of 2,084 million yen in its Dispensing Pharmacy Business due to a decline in profitability caused by a changing business environment. Consequently, the company has revised its full-year consolidated earnings forecast, reducing the net income attributable to shareholders by 45.9% to 2,000 million yen for the fiscal year ending March 31, 2025.
More about Nihon Chouzai Co
Nihon Chouzai Co., Ltd. operates in the dispensing pharmacy business, focusing on providing pharmaceutical services and products. The company is listed on the Tokyo Stock Exchange Prime Market.
YTD Price Performance: 0.0%
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $253.4M
Find detailed analytics on 3341 stock on TipRanks’ Stock Analysis page.
